Literature DB >> 11705567

Implications of the growing HIV-1 epidemic for tuberculosis control in Russia.

B Kazionny, C D Wells, H Kluge, N Gusseynova, V Molotilov.   

Abstract

Orel oblast, Russia, is the site of a WHO demonstration project for tuberculosis control. We used data acquired by the Center for Prevention of AIDS and Infectious Diseases to show that, in this region, the seroprevalence of HIV-1 infection has increased 33-fold in 4 years. The rapid spread of HIV-1 in Russia has serious implications for control of tuberculosis epidemics. Although the HIV-1 epidemic is at an early stage, aggressive prevention measures must be taken quickly to avoid the adverse effects of widespread HIV on tuberculosis control that have been seen in sub-Saharan Africa.

Entities:  

Mesh:

Year:  2001        PMID: 11705567     DOI: 10.1016/S0140-6736(01)06574-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients.

Authors:  M F Fleming; E Krupitsky; M Tsoy; E Zvartau; N Brazhenko; W Jakubowiak; M E McCaul
Journal:  Int J Tuberc Lung Dis       Date:  2006-05       Impact factor: 2.373

2.  CDC international HIV prevention research activities among injection drug users in Thailand and Russia.

Authors:  Alan E Greenberg; Jordan Tappero; Kachit Choopanya; Frits van Griensven; Mike Martin; Suphak Vanichseni; Scott Santibanez; Valerie Molotilov; Shannon Hader; Laura N Broyles
Journal:  J Urban Health       Date:  2005-09       Impact factor: 3.671

3.  Not all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia.

Authors:  Mark H Kuniholm; Malvina Aladashvili; Carlos Del Rio; Ketavan Stvilia; Nino Gabelia; Rohit A Chitale; Tengiz Tsertsvadze; Kenrad E Nelson
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

4.  Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method.

Authors:  Anandi Martin; Mirtha Camacho; Françoise Portaels; Juan Carlos Palomino
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

Review 5.  Extensively drug-resistant tuberculosis: a new face to an old pathogen.

Authors:  Sheela Shenoi; Gerald Friedland
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.